scholarly article | Q13442814 |
P356 | DOI | 10.1042/BCJ20190906 |
P698 | PubMed publication ID | 32039434 |
P2093 | author name string | Seongmin Lee | |
Hala Ouzon-Shubeita | |||
Caroline K Vilas | |||
P2860 | cites work | Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs | Q24644933 |
Structures of DNA Polymerase β with Active-Site Mismatches Suggest a Transient Abasic Site Intermediate during Misincorporation | Q27650580 | ||
DNA Polymerase Substrate Specificity: SIDE CHAIN MODULATION OF THE"A-RULE" | Q27657443 | ||
Structures of dNTP Intermediate States during DNA Polymerase Active Site Assembly | Q27672742 | ||
Binary complex crystal structure of DNA polymerase reveals multiple conformations of the templating 8-oxoguanine lesion | Q27676274 | ||
Stereospecific Formation of a Ternary Complex of (S)-α,β-Fluoromethylene-dATP with DNA Pol β | Q27677140 | ||
Amino Acid Substitution in the Active Site of DNA Polymerase β Explains the Energy Barrier of the Nucleotidyl Transfer Reaction | Q27678004 | ||
Structural basis of human DNA polymerase η-mediated chemoresistance to cisplatin. | Q27678705 | ||
Observing a DNA Polymerase Choose Right from Wrong | Q27678932 | ||
Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy | Q27678933 | ||
Metal-Dependent Conformational Activation Explains Highly Promutagenic Replication across O6-Methylguanine by Human DNA Polymerase β | Q27682793 | ||
Transition-state destabilization reveals how human DNA polymerase β proceeds across the chemically unstable lesion N7-methylguanine | Q27684466 | ||
Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism | Q27742804 | ||
Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents | Q28191144 | ||
DNA polymerase beta expression differences in selected human tumors and cell lines | Q28198269 | ||
The status of platinum anticancer drugs in the clinic and in clinical trials | Q28286605 | ||
A role for DNA polymerase beta in mutagenic UV lesion bypass | Q28570436 | ||
Cellular processing of platinum anticancer drugs | Q29617899 | ||
Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysis | Q33947166 | ||
Nucleotide excision repair from site-specifically platinum-modified nucleosomes. | Q51836720 | ||
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. | Q52720551 | ||
Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells. | Q54038050 | ||
Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. | Q54055057 | ||
Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line. | Q54391218 | ||
The side effects of platinum-based chemotherapy drugs: a review for chemists | Q55952286 | ||
DNA repair pathways and cisplatin resistance: an intimate relationship | Q58699219 | ||
Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta | Q81386042 | ||
Mutagenic Replication of the Major Oxidative Adenine Lesion 7,8-Dihydro-8-oxoadenine by Human DNA Polymerases | Q92003319 | ||
Cisplatin in cancer therapy: molecular mechanisms of action | Q34098163 | ||
Factors Contributing to Aromatic Stacking in Water: Evaluation in the Context of DNA. | Q34144275 | ||
C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency | Q34350141 | ||
Error-prone translesion synthesis mediates acquired chemoresistance | Q34376054 | ||
Structural basis for the inefficient nucleotide incorporation opposite cisplatin-DNA lesion by human DNA polymerase β. | Q34467599 | ||
The resurgence of platinum-based cancer chemotherapy | Q34649255 | ||
Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents | Q34774332 | ||
Molecular mechanisms of resistance and toxicity associated with platinating agents | Q35758048 | ||
Magnesium-induced assembly of a complete DNA polymerase catalytic complex. | Q35792408 | ||
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes | Q36105474 | ||
Cisplatin/carboplatin cross-resistance in ovarian cancer | Q36467911 | ||
Incorrect nucleotide insertion at the active site of a G:A mismatch catalyzed by DNA polymerase beta | Q36557917 | ||
Direct cellular responses to platinum-induced DNA damage | Q36800400 | ||
A comprehensive survey of the mutagenic impact of common cancer cytotoxics | Q36886849 | ||
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers | Q36958682 | ||
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance | Q37172320 | ||
Molecular mechanisms of cisplatin resistance | Q37926477 | ||
Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts | Q38321258 | ||
Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repair | Q40176489 | ||
Mutator phenotype of BCR--ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase beta | Q40951632 | ||
The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts | Q43548141 | ||
Loss of DNA polymerase beta stacking interactions with templating purines, but not pyrimidines, alters catalytic efficiency and fidelity. | Q43833668 | ||
Involvement of DNA polymerase beta in DNA replication and mutagenic consequences | Q43876611 | ||
In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic | Q45770163 | ||
Overexpression of DNA polymerase β: a genomic instability enhancer process | Q49816580 | ||
Acquired chemotherapy resistance in ovarian cancer. | Q49896015 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P1104 | number of pages | 15 | |
P304 | page(s) | 937-951 | |
P577 | publication date | 2020-03-01 | |
P1433 | published in | Biochemical Journal | Q864221 |
P1476 | title | Structural insights into the promutagenic bypass of the major cisplatin-induced DNA lesion | |
P478 | volume | 477 |